Image Description (Ic1)
Bludigo Injection
Product Images NDC 81284-315
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bludigo (NDC 81284-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Provepharm Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Carton Label (Ic3)
Bludigo is an injectable medication used intravenously. The medication is indigotindisulfonate sodium injection, USP with 40 mg/5 mL (8 mg/m). Each single dose ampule contains 5mL and 8 mg sodium. The medication is manufactured by CENEXI in France and distributed by Provepharm. The dosage of the medication should be as per the prescribing information enclosed. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F) and protected from light. Any unused portion of the medication should be discarded.*
Vial Label (Ic4)
Bludigom is a medication available in an injectable form intended for intravenous use only. It contains 40mg/5mL of indigotindisulfonate sodium and is sold in single-dose ampules. The medication is manufactured by CENEXI for PROVEPHARM SAS and distributed by PROVEPHARM, INC., with its address at 100 Springhouse Drive, Suite 105, Collegeville, PA 19426. It is Rx only and must be discarded after use. The lot number and expiration date provided is Lot EXP TN (01)00381284315005 Rev_07/2022.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
